1B) Human data is an excellent starting point, but it is not sufficient for a final formulation.

Some ingredients that are safe for humans can be inert or even toxic to pets (e.g., xylitol or certain essential oils).

Cats, as obligate carnivores, have unique liver enzyme pathways that change how they process botanicals and fats compared to humans or dogs. There is a critical shortage of feline-specific research; many “pet” supplements are actually “dog” supplements repackaged, leading to poor efficacy in cats.

 1E) Owners want to see the “farm-to-bowl” journey, often verified via QR codes on packaging. There is also a massive shift toward alternative proteins (insect, algae, or lab-grown) and upcycled ingredients to reduce the carbon pawprint.

Formulations are beginning to shed “hidden” ingredients like magnesium stearate or artificial palatants in favour of whole-food functional bases like pumpkin or cold-pressed oils.

Even manufacturers are pushing for sustainable ingredients, where they are looking to switch out some of their animal based products for ingredients like spent yeast - due to their sustainability commitments. 

2A) The “cleaner” the label, the challenge comes into mask the bitter taste of active botanicals or minerals. Cats are particularly fussy when it comes to unpleasant taste or textures, making liquid or powder-toppers more successful than hard tablets.

High-heat extrusion (kibble) destroys many bioactives. Manufacturers are pivoting to cold-pressing, freeze-drying, or dual-chamber packaging to keep actives stable until the moment of consumption, which can increase the cost for the end consumer.

With a move to including sustainable ’side streams/upcycling’ from the food industry, it creates variability in the input for formulations. 

2D)Smaller breeds have faster metabolisms but smaller mouths; mini-chews with high nutrient density are required. They are also smaller in body weight, and require far lower doses of bioactive than larger breeds.

The “Senior” category is the fastest-growing segment, requiring formulations that address multiple comorbidities (e.g., cognitive support + joint health) in one easy-to-digest format. In addition, as pets get older, they require slightly different formats of food ie softer to chew, more palatable etc

4A) Credibility will be key, as we move towards more standardisation and defined by Third-Party Validation of ingredients and their functionality.  Brands that invest in peer-reviewed, published clinical trials on their specific finished product (not just the raw ingredients) will dominate.

Supplements that are “Prescription-Grade” and recommended by vets will have the longest lifecycle.

4B) Currently, the gap between regulatory bodies for pet food globally. A global, standardized “Bioactive Certification” that mandates potency testing at the end of shelf-life (rather than just at manufacture) would instantly eliminate low-quality actors and solidify consumer trust.